Botox for Chronic Migraine in Delhi: Treatment, Cost & What to Expect
Chronic migraine can affect work, sleep, concentration, social activity and overall quality of life. For appropriately selected adults, BOTOX® (onabotulinumtoxinA) is an established preventive treatment used to reduce the frequency and overall burden of chronic migraine.
Botox for migraine treatment in Delhi is medically different from cosmetic Botox. Chronic-migraine treatment follows a defined injection pattern across specific areas of the head and neck, involves substantially greater total dosing and requires structured assessment of treatment response.
At The Face Clinic in Hauz Khas, South Delhi, treatment begins with clinical assessment rather than simply injecting the area where pain is felt.
The first questions are:
- Is the headache pattern consistent with chronic migraine?
- Has the diagnosis been appropriately established?
- Is onabotulinumtoxinA an appropriate preventive option?
- Have relevant previous treatments, medication use and medical history been reviewed?
BOTOX® may reduce migraine burden in patients who respond, but it does not cure migraine, and individual outcomes vary.
Medically reviewed by: Dr Reema Arora, MBBS, MSc Facial Aesthetics (UK)
Founder & Medical Director, The Face Clinic, Hauz Khas, New Delhi
Last medically reviewed: October 2026
Important: Chronic migraine is a neurological diagnosis. This page provides patient education and does not replace individual medical or neurological assessment.
BOTOX® for Chronic Migraine at a Glance
Clinical Question | Evidence-Based Overview |
Who is treatment intended for? | Adults with appropriately diagnosed chronic migraine |
What is chronic migraine? | Headache on ≥15 days/month for >3 months, with migraine features on ≥8 days/month |
Standard fixed PREEMPT dose | 155 Units |
Established PREEMPT range | 155–195 Units |
Injection pattern | 31–39 sites across defined head and neck regions |
Typical treatment interval | Approximately every 12 weeks |
Treatment objective | Reduce migraine frequency and overall burden—not cure migraine |
Indicative clinic cost | ₹65,000–₹90,000 per treatment session |
The strongest established clinical evidence relates to the 155–195 Unit PREEMPT framework. Migraine dosing should therefore not be estimated from cosmetic Botox doses or from the location in which a patient happens to feel pain.
What Is BOTOX® Treatment for Chronic Migraine?
BOTOX® is a branded formulation of onabotulinumtoxinA, a botulinum toxin type A preparation used for several medical and aesthetic indications.
In chronic migraine, its role is preventive.
It is not intended to stop an individual migraine attack after it has begun. Instead, treatment aims to reduce the frequency and overall burden of future headaches in patients who respond.
India’s Central Drugs Standard Control Organisation records an additional indication for botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine. See the CDSCO approved-drug records.
The applicable product information describes a recommended chronic-migraine dose of 155 Units administered across 31 defined intramuscular sites, with retreatment generally scheduled every 12 weeks.
This medical indication is fundamentally different from cosmetic Botox treatment in Delhi, where substantially smaller doses are typically placed into selected facial muscles to modify expression-related movement.
Who May Be Suitable for Migraine BOTOX®?
BOTOX® may be considered for adults who have been appropriately assessed as having chronic migraine.
The recognised diagnostic framework generally involves headache occurring on 15 or more days per month for more than three months, with migraine characteristics on at least eight days per month, according to the ICHD-3 definition of chronic migraine.
The distinction is important.
A person can experience severe, disabling migraine without meeting the criteria for chronic migraine, and Botox treatment should not be selected simply because headaches are frequent, severe or located around the forehead or temples.
Assessment should consider:
- total headache days per month;
- number of migraine days;
- duration and pattern of symptoms;
- previous and current preventive treatment;
- acute headache-medication use;
- possible medication-overuse headache;
- relevant medical and neurological history;
- other medicines and supplements;
- previous botulinum toxin treatment, where applicable; and
- whether another cause of headache requires investigation.
Chronic Migraine Should Be Appropriately Diagnosed Before Treatment
Frequent headaches alone do not establish chronic migraine.
Patients with a new headache disorder, unusual neurological symptoms, a substantial change in headache pattern or an uncertain diagnosis should receive appropriate medical assessment before injectable preventive treatment is considered.
Where chronic migraine has not already been adequately diagnosed, physician or neurological assessment may be appropriate before proceeding.
The objective should be to establish the diagnosis and indication first, rather than starting Botox solely because a patient reports recurrent forehead, temple or scalp pain.
Chronic vs Episodic Migraine
Chronic migraine and episodic migraine are not interchangeable.
Someone with episodic migraine may experience several severe attacks each month while still having fewer than 15 headache days per month.
The strongest evidence and established treatment framework for onabotulinumtoxinA relates specifically to chronic migraine.
People with episodic migraine may still require preventive treatment, but the appropriate option should be selected according to their diagnosis and individual medical circumstances rather than automatically applying the chronic-migraine BOTOX® protocol.
What About Frequent Painkiller or Triptan Use?
Frequent use of acute headache medicines can complicate chronic migraine and may contribute to medication-overuse headache in some patients.
Assessment should therefore include:
- how many days per month acute medication is taken;
- which medicines are being used;
- whether medication use has been increasing; and
- whether reduction or adjustment of acute treatment forms part of the broader migraine-management plan.
Medication overuse does not automatically exclude BOTOX®, but it should be recognised and addressed as part of the overall treatment strategy.
Migraine Triggers Are Not the Same as the Cause of Migraine
Migraine is a neurological disorder rather than simply a reaction to stress, food, muscle tension or lack of sleep.
Individual migraine attacks may nevertheless be influenced by triggers such as:
- disrupted sleep;
- stress;
- missed meals;
- dehydration;
- hormonal changes;
- alcohol; or
- particular sensory stimuli.
Recognising relevant triggers can be useful, but trigger avoidance alone is not a substitute for diagnosis and appropriate preventive treatment in someone with chronic migraine.
How Does BOTOX® Help Prevent Chronic Migraine?
The therapeutic effect of botulinum toxin in migraine treatment cannot be explained simply as relaxation of tense muscles.
After injection, onabotulinumtoxinA interferes with the release of signalling molecules involved in peripheral pain transmission. This is believed to reduce activation of pain pathways involved in migraine and may reduce headache frequency and burden in patients who respond.
Muscle relaxation can also occur because of the effect of botulinum toxin at the neuromuscular junction, but chronic-migraine treatment is not simply cosmetic Botox performed at different injection sites.
That distinction is particularly important for patients who are already familiar with Botox for facial lines.
The PREEMPT BOTOX® Protocol for Chronic Migraine
The best-established treatment framework for Botox for chronic migraine comes from the PREEMPT clinical programme.
Treatment follows a structured anatomical injection pattern rather than placing injections only where the patient feels pain on the treatment day.
The European Headache Federation consensus guideline on onabotulinumtoxinA for chronic migraine recommends administration according to the PREEMPT injection protocol.
How Many Units of BOTOX® Are Used for Chronic Migraine?
The standard fixed-site treatment uses:
155 Units of BOTOX® across 31 fixed injection sites.
The broader PREEMPT paradigm allows:
155–195 Units across 31–39 sites, generally at approximately 12-week treatment intervals.
Under the recognised follow-the-pain component of the PREEMPT paradigm, additional injections may be placed in specified temporalis, occipitalis and/or trapezius sites, taking the total treatment dose up to 195 Units.
The 155–195 Unit range therefore represents the clearest evidence-based protocol for chronic migraine.
BOTOX® Units are product-specific and should not be treated as equivalent to, or directly converted into, units of another botulinum toxin formulation.
Important Dose Distinction
Migraine Botox dosing should not be calculated from:
- cosmetic forehead Botox doses;
- cosmetic Botox price-per-area charts;
- the number of painful points;
- the number of forehead wrinkles; or
- an arbitrary low dose chosen solely to reduce treatment cost.
The therapeutic indication, injection pattern and total dosing are different.
Where Are Migraine BOTOX® Injections Given?
The fixed PREEMPT treatment pattern distributes injections across seven defined head and neck muscle regions:
- corrugator;
- procerus;
- frontalis;
- temporalis;
- occipitalis;
- cervical paraspinal muscle group; and
- trapezius.
The fixed treatment pattern comprises 31 injection sites, generally using 5 Units at each site.
Additional protocol-defined sites may be used in selected regions as part of the broader PREEMPT framework.
This is why Botox migraine injection sites should not be reduced to the idea of treating a few forehead, scalp or temple “trigger points.”
How Often Is BOTOX® Repeated for Chronic Migraine?
The recognised retreatment interval is approximately every 12 weeks.
Treatment should not simply be repeated indefinitely without assessing whether it is providing a meaningful clinical benefit.
Some patients notice improvement after the first treatment cycle, while others may require more than one cycle before response can be properly assessed.
How Effective Is BOTOX® for Chronic Migraine?
The pivotal PREEMPT clinical programme evaluated onabotulinumtoxinA in adults with chronic migraine.
The trials found a greater reduction in headache days in patients treated with onabotulinumtoxinA than with placebo. The PREEMPT pooled clinical analysis reported a statistically significant difference in headache-day reduction at 24 weeks.
However, clinical-trial results are population averages, not predictions of what will happen to an individual patient.
Treatment should therefore not be presented as:
- a guaranteed cure;
- a way to permanently eliminate migraine;
- certain to produce a specific percentage reduction;
- guaranteed to stop medication use; or
- a treatment that will make every patient migraine-free.
The clinically relevant question is whether treatment produces a meaningful reduction in headache burden, disability, severity and/or acute-medication use for that individual patient.
What Results Can Patients Realistically Expect?
For patients who respond, treatment may be associated with:
- fewer headache or migraine days;
- reduced severity of some attacks;
- shorter or less disabling attacks in some patients;
- reduced use of acute medication in some cases;
- improved ability to work or carry out everyday activities; and
- improvement in migraine-related quality of life.
Not every patient responds adequately.
A patient who continues to experience migraine after treatment may still have obtained a clinically meaningful benefit if headache frequency, severity or disability has decreased.
The goal is therefore reduction in migraine burden, rather than a promise of pain-free or migraine-free living.
How Is Treatment Response Measured?
A headache diary is one of the most useful tools for evaluating treatment.
Patients may be asked to record:
- total headache days;
- migraine days;
- attack severity;
- acute medication use;
- duration of attacks; and
- impact on work and everyday activities.
International headache guidance commonly evaluates response over the first two to three treatment cycles.
The European Headache Federation guideline uses less than approximately a 30% reduction in headache days as one definition of non-response, while also recognising factors such as headache intensity, disability and patient preference.
Continued treatment should therefore depend on measurable benefit, tolerability and the patient’s overall clinical picture.
What Does “Migraine Botox Before and After” Mean Clinically?
Patients sometimes search for migraine Botox before and after results expecting the kind of visual comparison used for cosmetic treatment.
That is not the appropriate way to evaluate chronic-migraine treatment.
For migraine, meaningful “before and after” assessment should compare:
- headache days per month;
- migraine days per month;
- attack severity;
- acute-medication use;
- disability; and
- effect on work, sleep and everyday activities.
Clinical outcome tracking is more meaningful than photographs because the purpose of treatment is migraine prevention, not facial alteration.
How Quickly Does Migraine BOTOX® Work?
BOTOX® is a preventive treatment rather than an immediate pain-relieving injection.
Some patients begin to notice improvement during the weeks following the first treatment cycle. Others require repeated treatment before the response becomes sufficiently clear.
Treatment should therefore not be judged solely by symptoms during the first few days after injection.
Where therapy is continued, repeat treatment is generally planned at approximately 12-week intervals, subject to response, tolerability and ongoing clinical assessment.
How Long Does Botox for Migraine Last?
The clinical treatment cycle is typically approximately 12 weeks, although an individual patient’s perceived duration of benefit may vary.
This does not mean that everyone should automatically receive treatment every three months indefinitely.
Continued treatment should take into account:
- clinical response;
- headache frequency;
- adverse effects;
- changes in diagnosis;
- other preventive therapies;
- patient preference; and
- ongoing medical suitability.
Side Effects and Safety of BOTOX® for Chronic Migraine
BOTOX® for chronic migraine is a medical treatment with recognised adverse effects, contraindications and precautions.
Possible treatment-related effects can include:
- injection-site discomfort;
- bruising;
- neck pain;
- temporary muscle weakness;
- eyelid drooping;
- headache; and
- temporary worsening of migraine in some patients.
Rare but potentially serious adverse effects associated with botulinum toxin products are described in the official BOTOX® prescribing information.
Patients should seek prompt medical attention if significant difficulty swallowing, speaking or breathing develops after treatment.
The correct approach is therefore not to describe migraine Botox as simply “safe,” but to assess the potential benefits, limitations and risks for the individual patient.
Who May Not Be Suitable for Migraine BOTOX®?
BOTOX® is contraindicated in circumstances including known hypersensitivity to the product or relevant components and infection at a proposed injection site.
Additional assessment may be important in patients with:
- certain neuromuscular conditions;
- previous swallowing or breathing difficulties;
- previous reactions to botulinum toxin products;
- recent treatment using another botulinum toxin product;
- medicines that may affect neuromuscular transmission;
- significant concurrent medical conditions; or
- pregnancy or breastfeeding.
Patients should provide a complete medication and medical history before treatment.
Do not stop prescribed anticoagulants, antiplatelet medicines, migraine medicines, pain medicines or other medication simply because you are considering BOTOX®.
Medication changes should be discussed with the clinician responsible for prescribing or managing those medicines.
What Happens During a Migraine BOTOX® Treatment Session?
Treatment begins with review of:
- migraine diagnosis;
- headache pattern and frequency;
- current medicines;
- previous preventive treatments;
- acute medication use;
- relevant medical history; and
- previous botulinum toxin treatment where applicable.
If onabotulinumtoxinA is considered appropriate, the treatment pattern is identified according to the therapeutic injection framework rather than simply following the location of pain on that particular day.
Multiple small injections are then administered across defined head and neck regions using a fine needle.
The injection component commonly takes approximately 15–20 minutes, although the complete appointment may be longer because of assessment and treatment planning.
Patients may experience brief pinprick or stinging sensations during treatment.
Most patients can return to normal routine activities afterwards, subject to individual medical advice.
Where Does BOTOX® Fit in Chronic Migraine Prevention?
There is no single preventive treatment that is appropriate for every person with chronic migraine.
Management may include:
- oral migraine-preventive medicines;
- CGRP-targeting preventive therapies;
- onabotulinumtoxinA;
- management of medication overuse where relevant;
- acute migraine treatment; and
- appropriate attention to sleep, hydration and individual triggers.
The purpose of consultation is therefore not simply to determine whether Botox can be injected.
The more useful question is:
Is BOTOX® an appropriate preventive treatment for this patient’s migraine diagnosis, treatment history, medical circumstances and previous response?
BOTOX® Migraine Treatment Cost in Delhi and India
For patients researching Botox migraine treatment cost in Delhi or migraine Botox treatment cost in India, it is important to distinguish therapeutic chronic-migraine treatment from cosmetic Botox pricing.
At The Face Clinic, the current indicative cost of BOTOX® treatment for chronic migraine is:
₹65,000–₹90,000 per treatment session
The final treatment cost may vary according to:
- the medically appropriate treatment plan;
- total dose used;
- relevant clinical circumstances;
- treatment complexity; and
- applicable consultation, review, GST or other charges.
The cost of Botox migraine treatment should not determine the therapeutic dose.
Migraine BOTOX® should also not automatically be priced by multiplying the clinic’s cosmetic Botox price per unit because therapeutic treatment follows a separate clinical protocol and may follow a separate pricing framework.
Patients researching cosmetic or general unit-based Botox pricing can refer to the clinic’s BOTOX® pricing in Delhi guide.
The applicable treatment plan and complete estimated cost should be clarified before treatment proceeds.
Choosing a Doctor for Botox Migraine Treatment in Delhi
Patients searching for a Botox migraine doctor in Delhi, migraine treatment doctor near me or Botox for migraines near me should consider more than advertising claims or treatment price.
Useful questions include:
- Has chronic migraine been appropriately diagnosed?
- Is the proposed dose consistent with recognised chronic-migraine guidance?
- Will treatment follow an established head-and-neck injection framework?
- Have previous migraine treatments been reviewed?
- Has medication overuse been considered?
- Are contraindications and relevant medical conditions being assessed?
- How will clinical response be measured?
- What happens if treatment is ineffective?
- Is neurological or headache-specialist assessment available or recommended when the diagnosis is uncertain?
Therapeutic migraine treatment is fundamentally different from cosmetic forehead Botox and should be approached accordingly.
Doctor-Led Assessment at The Face Clinic, South Delhi
BOTOX® for chronic migraine requires more than familiarity with cosmetic forehead injections.
Treatment involves:
- a defined therapeutic indication;
- substantially greater total dosing;
- multiple head and neck injection sites;
- detailed anatomical knowledge;
- appropriate patient selection; and
- structured monitoring of treatment response.
Dr Reema Arora is the Founder and Medical Director of The Face Clinic in Hauz Khas, New Delhi.
She is an MBBS doctor with an MSc in Facial Aesthetics (UK), has more than 20 years of experience in facial aesthetics and injectable treatments, and previously served as Medical Head – Facial Aesthetics at Allergan India.
Her experience with botulinum toxin is relevant to anatomy and injection technique.
However, chronic migraine itself is a neurological diagnosis.
Treatment should therefore proceed only when the diagnosis and therapeutic indication are sufficiently established.
Where symptoms are atypical, the diagnosis remains uncertain, the headache pattern has changed or neurological assessment is otherwise clinically indicated, appropriate medical or specialist evaluation should form part of the treatment pathway.
The objective is a medically appropriate treatment decision—not simply proceeding because a patient requests Botox for headaches.
Frequently Asked Questions About BOTOX® for Migraine
Is migraine BOTOX® the same as cosmetic Botox?
No.
Both may involve onabotulinumtoxinA, but chronic-migraine treatment uses a specific therapeutic injection framework involving substantially greater total doses and multiple head and neck sites.
Cosmetic treatment generally targets selected facial muscles to modify expression-related movement.
For information about aesthetic use, see cosmetic Botox injections in Delhi.
How many Units of BOTOX® are used for chronic migraine?
The standard fixed PREEMPT dose is 155 Units across 31 injection sites.
The broader recognised PREEMPT framework allows treatment up to 195 Units across 39 sites in specified circumstances.
Migraine dosing should not be estimated from cosmetic Botox treatment.
Why are so many injections needed?
Chronic-migraine BOTOX® is based on a structured treatment pattern involving multiple areas across the head and neck.
It therefore differs from treating only the forehead, temples or the particular area where pain is felt.
How often is migraine BOTOX® repeated?
The established treatment interval is approximately every 12 weeks.
Whether treatment should continue depends on response, tolerability and ongoing clinical assessment.
How long does it take to know whether Botox is working?
Some patients notice improvement after the first treatment cycle, while others may require additional cycles before response becomes sufficiently clear.
A headache diary can help measure changes in headache days, migraine days, severity, medication use and functional impact.
Response is commonly assessed across the first two to three treatment cycles.
Can BOTOX® cure chronic migraine?
No.
BOTOX® is a preventive treatment intended to reduce the frequency and overall burden of chronic migraine in patients who respond.
It should not be described as a cure or a guarantee of migraine-free living.
Will migraine BOTOX® change how my face looks?
The purpose of treatment is migraine prevention rather than cosmetic alteration.
Because some treatment sites involve muscles of the forehead and upper face, however, changes in muscle movement or appearance can occur in some patients.
Injection planning should prioritise the therapeutic treatment protocol while also considering individual anatomy.
Can I continue my existing migraine medicines?
Often, existing migraine medicines can be continued, but this depends on the individual treatment plan.
Do not stop, start or alter prescribed migraine medication because of BOTOX® treatment without discussing the change with the clinician responsible for managing the medication.
Can BOTOX® be used for episodic migraine?
The established indication and strongest evidence relate to chronic migraine.
People with episodic migraine may still benefit from preventive treatment, but the appropriate therapy should be selected according to their diagnosis and individual clinical circumstances.
Does forehead Botox treat headaches?
Forehead pain alone does not establish chronic migraine or mean that forehead Botox is appropriate.
Headaches have many possible causes.
Persistent, recurrent, changing or unexplained headache should be medically assessed rather than treated according to the location of pain alone.
Is BOTOX® for migraine safe?
OnabotulinumtoxinA has an established evidence base for chronic migraine, but it can cause adverse effects and is not appropriate for everyone.
Suitability should therefore be based on an individual benefit–risk assessment rather than describing treatment as universally safe.
How much does BOTOX® for migraine cost in Delhi?
At The Face Clinic, the current indicative cost is approximately:
₹50,000–₹90,000 per treatment session.
The final amount depends on the medically appropriate treatment plan and applicable charges.
What affects the cost of Botox migraine treatment?
The total treatment cost may be influenced by the medically appropriate dose, treatment pattern, clinical assessment and applicable professional or clinic charges.
The therapeutic dose should not be reduced solely to achieve a lower price.
How should I choose a clinic when searching for “Botox for migraines near me”?
Look beyond proximity and advertised price.
Important considerations include appropriate diagnosis, knowledge of the recognised chronic-migraine treatment protocol, medical-history assessment, appropriate dosing, management of contraindications, follow-up and the ability to refer for neurological or headache-specialist assessment when required.
Considering BOTOX® for Chronic Migraine in Delhi?
If you experience frequent migraine and are considering Botox migraine treatment in Delhi, India, the first step is determining whether your headache pattern is consistent with chronic migraine and whether onabotulinumtoxinA is an appropriate preventive option.
A structured consultation may review:
- headache frequency;
- migraine characteristics;
- current medication;
- acute medication use;
- previous preventive treatment;
- relevant medical history; and
- suitability for BOTOX® treatment.
You can book a doctor consultation at The Face Clinic in Hauz Khas, South Delhi.
A consultation does not mean that treatment will necessarily be recommended.
The objective is to establish whether the treatment is medically appropriate and to discuss realistic expectations regarding potential benefit, limitations, adverse effects, treatment frequency and cost.
Medical Review & Selected References
Medically reviewed by:
Dr Reema Arora, MBBS, MSc Facial Aesthetics (UK)
Founder & Medical Director, The Face Clinic
Hauz Khas, New Delhi
Last medically reviewed: October 2026
Selected Clinical and Regulatory Sources
— confirms the additional chronic-migraine indication for botulinum toxin type A in India.
- ICHD-3 definition of chronic migraine — recognised diagnostic criteria for chronic migraine.
- European Headache Federation consensus guideline on onabotulinumtoxinA for chronic migraine — supports the PREEMPT 155–195 Unit, 31–39-site, 12-week treatment framework.
- PREEMPT pooled clinical analysis — pivotal clinical evidence evaluating onabotulinumtoxinA in adults with chronic migraine.
- PREEMPT 56-week pooled analysis — longer-term analysis of repeated onabotulinumtoxinA treatment cycles in chronic migraine.
Medical Disclaimer
This page provides general educational information about onabotulinumtoxinA/BOTOX® treatment for chronic migraine.
It does not provide a diagnosis, replace individual medical advice or establish that treatment is suitable for a particular person.
All treatments are subject to individual variation. Outcomes are determined following clinical evaluation by a qualified doctor.
